Key result
H-FABP demonstrated greater sensitivity, specificity, and ROC area under curve compared to CK-MB and myoglobin for the diagnosis of AMI within 6 hours of symptom onset.
Why the study?
Does H-FABP measurement improve the early diagnosis of AMI compared to CK-MB and myoglobin in patients with suspected AMI within 6 hours of symptom onset?
Case-Control (n=80)
Does H-FABP measurement improve the early diagnosis of AMI compared to CK-MB and myoglobin in patients with suspected AMI within 6 hours of symptom onset?
H-FABP is a superior biomarker to CK-MB and myoglobin for the early diagnosis of acute myocardial infarction within 6 hours of symptom onset.
Answers are grounded in this paper and cite their sources.
May aid early AMI diagnosis; hypothesis-generating in case-control data, needs prospective validation.
BACKGROUND: Early diagnosis and therapeutic intervention can improve the outcome of acute myocardial infarction (AMI). However, there are no satisfactory cardiac biomarkers for the diagnosis of AMI within 6 hours of onset of symptoms. Among novel biochemical markers of AMI, heart-type fatty acid binding protein (H-FABP) is of particular interest. AIM: To compare the diagnostic value of H-FABP with that of CK-MB and myoglobin in suspected AMI patients within first 6 hours after the onset of symptoms. SETTINGS AND DESIGN: The study includes 40 AMI cases and 40 non-cardiac chest pain otherwise healthy controls. The cases and controls were further divided into 2 groups depending on the time since chest pain as those subjects within 3 hours and those between 3-6 hours of onset of chest pain. MATERIALS AND METHODS: In all the cases and controls, serum H-FABP, CK-MB and myoglobin concentrations were measured by Immunoturbidimetric method, immuno-inhibition method and Chemiluminescence immunoassay respectively. STATISTICAL ANALYSIS: Data is presented as mean ± SD values. Differences between means of two groups were assessed by Student t-test. Sensitivity, Specificity, Positive predictive value, Negative predictive values were calculated and ROC curve analysis was done to assess the diagnostic validity of each study parameter. RESULTS: The sensitivity, specificity, PPV, NPV of H-FABP were greater than CK-MB and myoglobin and ROC curve analysis demonstrated highest area under curve for H-FABP followed by myoglobin and CK-MB in patients with suspected AMI both within 3 hours and 3-6 hours after the onset of chest pain. CONCLUSION: The diagnostic efficiency of H-FABP is greater than CK-MB and myoglobin for the early diagnosis of AMI within first 6 hours of chest pain. H-FABP can be used as an additional diagnostic tool for the early diagnosis of AMI.
No takes yet. Share an insight, caveat, or question.
Anand K Pyati (2015) conducted a case-control in Acute Myocardial Infarction (n=80). Heart-type fatty acid binding protein (H-FABP) vs. CK-MB and myoglobin was evaluated on Diagnostic validity (sensitivity, specificity, PPV, NPV, and ROC curve analysis). H-FABP demonstrated greater sensitivity, specificity, and ROC area under curve compared to CK-MB and myoglobin for the diagnosis of AMI within 6 hours of symptom onset.
Synapse has enriched 10 related papers. Consider them for comparative context: